Several reports have demonstrated that activating AMPK by 5-aminoimidazole-4-carboxamide-ribonucleoside (AICAR) or phenformin in human cancer cells results in apoptosis by several mechanisms, including modulating the MAPK pathway [39, 40]. Here, PRKAA2 is linked to cancer.